Pharmacological activation of PPARβ/δ preserves mitochondrial respiratory function in ischemia/reperfusion via stimulation of fatty acid oxidation-linked respiration and PGC-1α/NRF-1 signaling

Myocardial ischemia/reperfusion (I/R) injury leads to significant impairment of cardiac function and remains the leading cause of morbidity and mortality worldwide. Activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) confers cardioprotection via pleiotropic effects including antio...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in endocrinology (Lausanne) Vol. 13; p. 941822
Main Authors: Papatheodorou, Ioanna, Makrecka-Kuka, Marina, Kuka, Janis, Liepinsh, Edgars, Dambrova, Maija, Lazou, Antigone
Format: Journal Article
Language:English
Published: Frontiers Media S.A 15.08.2022
Subjects:
ISSN:1664-2392, 1664-2392
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Myocardial ischemia/reperfusion (I/R) injury leads to significant impairment of cardiac function and remains the leading cause of morbidity and mortality worldwide. Activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) confers cardioprotection via pleiotropic effects including antioxidant and anti-inflammatory actions; however, the underlying mechanisms are not yet fully elucidated. The aim of this study was to investigate the effect of PPARβ/δ activation on myocardial mitochondrial respiratory function and link this effect with cardioprotection after ischemia/reperfusion (I/R). For this purpose, rats were treated with the PPARβ/δ agonist GW0742 and/or antagonist GSK0660 in vivo . Mitochondrial respiration and ROS production rates were determined using high-resolution fluororespirometry. Activation of PPARβ/δ did not alter mitochondrial respiratory function in the healthy heart, however, inhibition of PPARβ/δ reduced fatty acid oxidation (FAO) and complex II-linked mitochondrial respiration and shifted the substrate dependence away from succinate-related energy production and towards NADH. Activation of PPARβ/δ reduced mitochondrial stress during in vitro anoxia/reoxygenation. Furthermore, it preserved FAO-dependent mitochondrial respiration and lowered ROS production at oxidative phosphorylation (OXPHOS)-dependent state during ex vivo I/R. PPARβ/δ activation was also followed by increased mRNA expression of components of FAO -linked respiration and of transcription factors governing mitochondrial homeostasis (carnitine palmitoyl transferase 1b and 2-CPT-1b and CPT-2, electron transfer flavoprotein dehydrogenase -ETFDH, peroxisome proliferator-activated receptor gamma co-activator 1 alpha- PGC-1α and nuclear respiratory factor 1-NRF-1). In conclusion, activation of PPARβ/δ stimulated both FAO-linked respiration and PGC-1α/NRF -1 signaling and preserved mitochondrial respiratory function during I/R. These effects are associated with reduced infarct size.
AbstractList Myocardial ischemia/reperfusion (I/R) injury leads to significant impairment of cardiac function and remains the leading cause of morbidity and mortality worldwide. Activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) confers cardioprotection via pleiotropic effects including antioxidant and anti-inflammatory actions; however, the underlying mechanisms are not yet fully elucidated. The aim of this study was to investigate the effect of PPARβ/δ activation on myocardial mitochondrial respiratory function and link this effect with cardioprotection after ischemia/reperfusion (I/R). For this purpose, rats were treated with the PPARβ/δ agonist GW0742 and/or antagonist GSK0660 in vivo. Mitochondrial respiration and ROS production rates were determined using high-resolution fluororespirometry. Activation of PPARβ/δ did not alter mitochondrial respiratory function in the healthy heart, however, inhibition of PPARβ/δ reduced fatty acid oxidation (FAO) and complex II-linked mitochondrial respiration and shifted the substrate dependence away from succinate-related energy production and towards NADH. Activation of PPARβ/δ reduced mitochondrial stress during in vitro anoxia/reoxygenation. Furthermore, it preserved FAO-dependent mitochondrial respiration and lowered ROS production at oxidative phosphorylation (OXPHOS)-dependent state during ex vivo I/R. PPARβ/δ activation was also followed by increased mRNA expression of components of FAO -linked respiration and of transcription factors governing mitochondrial homeostasis (carnitine palmitoyl transferase 1b and 2-CPT-1b and CPT-2, electron transfer flavoprotein dehydrogenase -ETFDH, peroxisome proliferator-activated receptor gamma co-activator 1 alpha- PGC-1α and nuclear respiratory factor 1-NRF-1). In conclusion, activation of PPARβ/δ stimulated both FAO-linked respiration and PGC-1α/NRF -1 signaling and preserved mitochondrial respiratory function during I/R. These effects are associated with reduced infarct size.Myocardial ischemia/reperfusion (I/R) injury leads to significant impairment of cardiac function and remains the leading cause of morbidity and mortality worldwide. Activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) confers cardioprotection via pleiotropic effects including antioxidant and anti-inflammatory actions; however, the underlying mechanisms are not yet fully elucidated. The aim of this study was to investigate the effect of PPARβ/δ activation on myocardial mitochondrial respiratory function and link this effect with cardioprotection after ischemia/reperfusion (I/R). For this purpose, rats were treated with the PPARβ/δ agonist GW0742 and/or antagonist GSK0660 in vivo. Mitochondrial respiration and ROS production rates were determined using high-resolution fluororespirometry. Activation of PPARβ/δ did not alter mitochondrial respiratory function in the healthy heart, however, inhibition of PPARβ/δ reduced fatty acid oxidation (FAO) and complex II-linked mitochondrial respiration and shifted the substrate dependence away from succinate-related energy production and towards NADH. Activation of PPARβ/δ reduced mitochondrial stress during in vitro anoxia/reoxygenation. Furthermore, it preserved FAO-dependent mitochondrial respiration and lowered ROS production at oxidative phosphorylation (OXPHOS)-dependent state during ex vivo I/R. PPARβ/δ activation was also followed by increased mRNA expression of components of FAO -linked respiration and of transcription factors governing mitochondrial homeostasis (carnitine palmitoyl transferase 1b and 2-CPT-1b and CPT-2, electron transfer flavoprotein dehydrogenase -ETFDH, peroxisome proliferator-activated receptor gamma co-activator 1 alpha- PGC-1α and nuclear respiratory factor 1-NRF-1). In conclusion, activation of PPARβ/δ stimulated both FAO-linked respiration and PGC-1α/NRF -1 signaling and preserved mitochondrial respiratory function during I/R. These effects are associated with reduced infarct size.
Myocardial ischemia/reperfusion (I/R) injury leads to significant impairment of cardiac function and remains the leading cause of morbidity and mortality worldwide. Activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) confers cardioprotection via pleiotropic effects including antioxidant and anti-inflammatory actions; however, the underlying mechanisms are not yet fully elucidated. The aim of this study was to investigate the effect of PPARβ/δ activation on myocardial mitochondrial respiratory function and link this effect with cardioprotection after ischemia/reperfusion (I/R). For this purpose, rats were treated with the PPARβ/δ agonist GW0742 and/or antagonist GSK0660 in vivo. Mitochondrial respiration and ROS production rates were determined using high-resolution fluororespirometry. Activation of PPARβ/δ did not alter mitochondrial respiratory function in the healthy heart, however, inhibition of PPARβ/δ reduced fatty acid oxidation (FAO) and complex II-linked mitochondrial respiration and shifted the substrate dependence away from succinate-related energy production and towards NADH. Activation of PPARβ/δ reduced mitochondrial stress during in vitro anoxia/reoxygenation. Furthermore, it preserved FAO-dependent mitochondrial respiration and lowered ROS production at oxidative phosphorylation (OXPHOS)-dependent state during ex vivo I/R. PPARβ/δ activation was also followed by increased mRNA expression of components of FAO -linked respiration and of transcription factors governing mitochondrial homeostasis (carnitine palmitoyl transferase 1b and 2-CPT-1b and CPT-2, electron transfer flavoprotein dehydrogenase -ETFDH, peroxisome proliferator-activated receptor gamma co-activator 1 alpha- PGC-1α and nuclear respiratory factor 1-NRF-1). In conclusion, activation of PPARβ/δ stimulated both FAO-linked respiration and PGC-1α/NRF -1 signaling and preserved mitochondrial respiratory function during I/R. These effects are associated with reduced infarct size.
Myocardial ischemia/reperfusion (I/R) injury leads to significant impairment of cardiac function and remains the leading cause of morbidity and mortality worldwide. Activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) confers cardioprotection via pleiotropic effects including antioxidant and anti-inflammatory actions; however, the underlying mechanisms are not yet fully elucidated. The aim of this study was to investigate the effect of PPARβ/δ activation on myocardial mitochondrial respiratory function and link this effect with cardioprotection after ischemia/reperfusion (I/R). For this purpose, rats were treated with the PPARβ/δ agonist GW0742 and/or antagonist GSK0660 in vivo . Mitochondrial respiration and ROS production rates were determined using high-resolution fluororespirometry. Activation of PPARβ/δ did not alter mitochondrial respiratory function in the healthy heart, however, inhibition of PPARβ/δ reduced fatty acid oxidation (FAO) and complex II-linked mitochondrial respiration and shifted the substrate dependence away from succinate-related energy production and towards NADH. Activation of PPARβ/δ reduced mitochondrial stress during in vitro anoxia/reoxygenation. Furthermore, it preserved FAO-dependent mitochondrial respiration and lowered ROS production at oxidative phosphorylation (OXPHOS)-dependent state during ex vivo I/R. PPARβ/δ activation was also followed by increased mRNA expression of components of FAO -linked respiration and of transcription factors governing mitochondrial homeostasis (carnitine palmitoyl transferase 1b and 2-CPT-1b and CPT-2, electron transfer flavoprotein dehydrogenase -ETFDH, peroxisome proliferator-activated receptor gamma co-activator 1 alpha- PGC-1α and nuclear respiratory factor 1-NRF-1). In conclusion, activation of PPARβ/δ stimulated both FAO-linked respiration and PGC-1α/NRF -1 signaling and preserved mitochondrial respiratory function during I/R. These effects are associated with reduced infarct size.
Author Lazou, Antigone
Makrecka-Kuka, Marina
Kuka, Janis
Liepinsh, Edgars
Papatheodorou, Ioanna
Dambrova, Maija
AuthorAffiliation 2 Laboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis , Riga , Latvia
3 Faculty of Pharmacy, Riga Stradins University , Riga , Latvia
1 Laboratory of Animal Physiology, Department of Zoology, School of Biology, Aristotle University of Thessaloniki , Thessaloniki , Greece
AuthorAffiliation_xml – name: 3 Faculty of Pharmacy, Riga Stradins University , Riga , Latvia
– name: 1 Laboratory of Animal Physiology, Department of Zoology, School of Biology, Aristotle University of Thessaloniki , Thessaloniki , Greece
– name: 2 Laboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis , Riga , Latvia
Author_xml – sequence: 1
  givenname: Ioanna
  surname: Papatheodorou
  fullname: Papatheodorou, Ioanna
– sequence: 2
  givenname: Marina
  surname: Makrecka-Kuka
  fullname: Makrecka-Kuka, Marina
– sequence: 3
  givenname: Janis
  surname: Kuka
  fullname: Kuka, Janis
– sequence: 4
  givenname: Edgars
  surname: Liepinsh
  fullname: Liepinsh, Edgars
– sequence: 5
  givenname: Maija
  surname: Dambrova
  fullname: Dambrova, Maija
– sequence: 6
  givenname: Antigone
  surname: Lazou
  fullname: Lazou, Antigone
BookMark eNp9Uk1uEzEYHaEiWkoPwG6WbCaxPR7PeINUVbRUqiCqYG1945_EZcYOthM1xwJxA_Y5E05SRZQFliVbz-_Hst_r4sR5p4viLUaTuu741Gin_IQgQiac4o6QF8UZZoxWpObk5K_9aXER4wPKgyLMefeqOK0Zoqzt2Fnxe7aAMIL0g59bCUMJMtk1JOtd6U05m13eb39Ot7_KZdBRh7WO5WiTlwvvVLCZn-GlDZB82JRm5eReafOMcqFHC9OglzqYVdzhawtlTHZcDccEAyltcqpVpX-0ao9Xg3XftDp676jgVDm7uarw9sf00_11hcto5w4yc_6meGlgiPriaT0vvl5_-HL1sbr7fHN7dXlXSUpJqiSvG2Q41oxSxRCWuGmowgYp0vWdbBUDhbhpW84bivsW9bTjvUFS9y1HBurz4vbgqzw8iGWwI4SN8GDFHvBhLiAkKwct-qYGzhkCqIEaaDqQrMeEs55r0kmTvd4fvJarftRKapcCDM9Mn584uxBzvxacEsQ5zQbvngyC_77SMYkxP7keBnDar6IgLeIIM1zjTMUHqgw-xqDNMQYjseuS2HdJ7LokDl3KmvYfjbRp_xP5Nnb4j_IPddfYfA
CitedBy_id crossref_primary_10_1016_j_intimp_2024_113307
crossref_primary_10_32604_biocell_2024_053930
crossref_primary_10_1016_j_yjmcc_2023_08_005
crossref_primary_10_3892_mmr_2024_13382
crossref_primary_10_2147_JIR_S530737
crossref_primary_10_1080_07391102_2023_2268185
crossref_primary_10_1016_j_ijbiomac_2023_125008
crossref_primary_10_25259_Cytojournal_12_2025
crossref_primary_10_1007_s12011_024_04450_8
crossref_primary_10_3389_fendo_2023_1210455
crossref_primary_10_3390_antiox13040405
crossref_primary_10_2147_DDDT_S474628
crossref_primary_10_1007_s10753_024_02211_2
crossref_primary_10_1016_j_biopha_2023_114827
crossref_primary_10_1055_a_2043_7707
Cites_doi 10.1146/annurev-pharmtox-010715-103335
10.1161/JAHA.118.009540
10.1177/1074248411419502
10.1111/jcmm.15127
10.1016/S0021-9258(19)52451-6
10.1016/j.tem.2012.06.006
10.1038/s41569-020-0403-y
10.1172/JCI62874
10.1124/jpet.107.135327
10.1111/j.1476-5381.2010.00873.x
10.1016/j.bbalip.2010.11.002
10.1016/j.freeradbiomed.2021.01.036
10.1007/s00395-021-00893-5
10.1016/j.vascn.2012.11.001
10.1161/HYPERTENSIONAHA.110.164590
10.1139/cjpp-2014-0502
10.1007/978-1-61779-382-0_3
10.1152/ajpheart.00335.2017
10.4149/gpb_2011_04_329
10.1210/endo.137.1.8536636
10.1016/j.ebiom.2020.102884
10.1097/shk.0b013e3181cd86d6
10.1016/j.jmb.2007.06.091
10.1007/978-1-4939-2257-4_22
10.1161/CIRCRESAHA.109.206185
10.3892/ijmm.2019.4188
10.1371/journal.pbio.1000412
10.21775/cimb.028.029
10.1007/s00125-011-2401-4
10.1016/j.pharmthera.2008.08.002
10.1161/circulationaha.107.670588
10.1007/s00395-018-0696-8
10.1016/j.phrs.2015.03.008
10.1007/s00210-013-0849-0
10.1152/ajpheart.00747.2013
10.1161/01.res.0000060700.55247.7c
10.1161/CIRCRESAHA.110.217380
10.1161/CIRCRESAHA.114.300559
10.3390/antiox8100454
10.1152/ajpcell.00270.2006
10.1111/1755-5922.12166
10.1161/01.res.0000141774.29937.e3
10.1016/j.yjmcc.2008.03.021
10.3390/biom5031319
10.1074/jbc.M709741200
10.1042/bcj20160164
10.3390/ijms22126399
10.33549/physiolres.932597
ContentType Journal Article
Copyright Copyright © 2022 Papatheodorou, Makrecka-Kuka, Kuka, Liepinsh, Dambrova and Lazou.
Copyright © 2022 Papatheodorou, Makrecka-Kuka, Kuka, Liepinsh, Dambrova and Lazou 2022 Papatheodorou, Makrecka-Kuka, Kuka, Liepinsh, Dambrova and Lazou
Copyright_xml – notice: Copyright © 2022 Papatheodorou, Makrecka-Kuka, Kuka, Liepinsh, Dambrova and Lazou.
– notice: Copyright © 2022 Papatheodorou, Makrecka-Kuka, Kuka, Liepinsh, Dambrova and Lazou 2022 Papatheodorou, Makrecka-Kuka, Kuka, Liepinsh, Dambrova and Lazou
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fendo.2022.941822
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1664-2392
ExternalDocumentID oai_doaj_org_article_b53a9960aa3a4fa58ac6b1296b9e28cf
PMC9420994
10_3389_fendo_2022_941822
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RPM
7X8
5PM
ID FETCH-LOGICAL-c442t-c9350f91e644d601c1554d1f0d28b8c7d6ad09f7799541b70b489bf0ceb790fa3
IEDL.DBID DOA
ISICitedReferencesCount 17
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000848383600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1664-2392
IngestDate Fri Oct 03 12:39:47 EDT 2025
Tue Sep 30 16:43:43 EDT 2025
Thu Oct 02 06:56:47 EDT 2025
Tue Nov 18 22:06:04 EST 2025
Sat Nov 29 06:38:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c442t-c9350f91e644d601c1554d1f0d28b8c7d6ad09f7799541b70b489bf0ceb790fa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Sruti Shiva, University of Pittsburgh, United States; Pasquale Pagliaro, University of Turin, Italy; Gerd Heusch, University of Duisburg-Essen, Germany; Puneet Randhawa, University of Central Florida, United States
This article was submitted to Cellular Endocrinology, a section of the journal Frontiers in Endocrinology
Edited by: Guillermo Romero, University of Pittsburgh, United States
OpenAccessLink https://doaj.org/article/b53a9960aa3a4fa58ac6b1296b9e28cf
PMID 36046786
PQID 2709016131
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_b53a9960aa3a4fa58ac6b1296b9e28cf
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9420994
proquest_miscellaneous_2709016131
crossref_primary_10_3389_fendo_2022_941822
crossref_citationtrail_10_3389_fendo_2022_941822
PublicationCentury 2000
PublicationDate 2022-08-15
PublicationDateYYYYMMDD 2022-08-15
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-15
  day: 15
PublicationDecade 2020
PublicationTitle Frontiers in endocrinology (Lausanne)
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Ravingerová (B15) 2015; 93
Kapoor (B23) 2010; 34
Hausenloy (B1) 2013; 123
Wang (B19) 2010; 106
Ramachandra (B8) 2020; 57
Kuka (B31) 2012; 17
Zhao (B9) 2019; 44
Serrano-Marco (B39) 2011; 55
Finck (B47) 2007; 115
Pesta (B29) 2012; 810
Krumschnabel (B30) 2015; 1264
Lesnefsky (B41) 2017; 57
Chen (B42) 2007; 292
Liepinsh (B45) 2013; 386
Boengler (B40) 2008; 120
Piantadosi (B37) 2008; 283
Georgiadi (B34) 2010; 106
Bøtker (B4) 2018; 113
Kleinbongard (B11) 2018; 7
Braissant (B17) 1996; 137
Ravingerová (B13) 2011; 30
Dambrova (B43) 2021; 165
Degenhardt (B33) 2007; 372
Lecour (B5) 2021; 116
Kilkenny (B25) 2010
Liepinsh (B32) 2013; 67
Álvarez-Guardia (B38) 2011; 1811
Liepinsh (B44) 2016; 473
Yue (B22) 2008; 325
Barlaka (B21) 2015
Di (B46) 2018; 28
Hollander (B48) 2014; 307
Heusch (B2) 2020; 17
Davidson (B7) 2020; 24
Liu (B20) 2011; 57
Gnaiger (B10) 2014
Ravingerová (B14) 2013; 62
Gilde (B18) 2003; 92
Barlaka (B16) 2016; 34
McGrath (B26) 2010; 160
Scarpulla (B36) 2012; 23
Lindsey (B3) 2018; 314
Lowry (B28) 1951; 193
Huss (B35) 2004; 95
Chen (B49) 2014; 114
Kuznetsov (B6) 2019; 8
Papatheodorou (B24) 2021; 22
Makrecka-Kuka (B27) 2015; 5
Madrazo (B12) 2008; 44
References_xml – volume: 57
  year: 2017
  ident: B41
  article-title: Mitochondrial dysfunction and myocardial ischemia-reperfusion: Implications for novel therapies
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev-pharmtox-010715-103335
– volume: 7
  year: 2018
  ident: B11
  article-title: Mitochondrial and contractile function of human right atrial tissue in response to remote ischemic conditioning
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.118.009540
– volume: 17
  year: 2012
  ident: B31
  article-title: The cardioprotective effect of mildronate is diminished after co-treatment with l-carnitine
  publication-title: J Cardiovasc Pharmacol Ther
  doi: 10.1177/1074248411419502
– volume: 24
  year: 2020
  ident: B7
  article-title: Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.15127
– volume: 193
  year: 1951
  ident: B28
  article-title: Protein measurement with the folin phenol reagent
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)52451-6
– volume: 23
  year: 2012
  ident: B36
  article-title: Transcriptional integration of mitochondrial biogenesis
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2012.06.006
– volume: 17
  year: 2020
  ident: B2
  article-title: Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
  publication-title: Nat Rev Cardiol
  doi: 10.1038/s41569-020-0403-y
– volume: 123
  start-page: 92
  year: 2013
  ident: B1
  article-title: Myocardial ischemia-reperfusion injury: A neglected therapeutic target
  publication-title: J Clin Invest
  doi: 10.1172/JCI62874
– volume: 325
  year: 2008
  ident: B22
  article-title: In vivo activation of peroxisome proliferator-activated receptor-δ protects the heart from Ischemia/Reperfusion injury in zucker fatty rats
  publication-title: J Pharmacol Exper Ther
  doi: 10.1124/jpet.107.135327
– volume: 160
  year: 2010
  ident: B26
  article-title: Guidelines for reporting experiments involving animals: the ARRIVE guidelines
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.2010.00873.x
– volume: 1811
  start-page: 59
  year: 2011
  ident: B38
  article-title: PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells
  publication-title: Biochim Biophys Acta (BBA) Mol Cell Biol Lipids
  doi: 10.1016/j.bbalip.2010.11.002
– volume: 165
  start-page: 24
  year: 2021
  ident: B43
  article-title: Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injury
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2021.01.036
– volume: 116
  year: 2021
  ident: B5
  article-title: IMproving preclinical assessment of cardioprotective therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST action
  publication-title: Basic Res Cardiol
  doi: 10.1007/s00395-021-00893-5
– volume: 67
  start-page: 98
  year: 2013
  ident: B32
  article-title: Troubleshooting digital macro photography for image acquisition and the analysis of biological samples
  publication-title: J Pharmacol Toxicol Methods
  doi: 10.1016/j.vascn.2012.11.001
– volume: 57
  year: 2011
  ident: B20
  article-title: Peroxisome proliferator-activated receptor β/δ activation in adult hearts facilitates mitochondrial function and cardiac performance under pressure-overload condition
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.110.164590
– volume: 93
  start-page: 495
  year: 2015
  ident: B15
  article-title: Pleiotropic preconditioning-like cardioprotective effects of hypolipidemic drugs in acute ischemia–reperfusion in normal and hypertensive rats
  publication-title: Can J Physiol Pharmacol
  doi: 10.1139/cjpp-2014-0502
– volume: 810
  start-page: 25
  year: 2012
  ident: B29
  article-title: High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle
  publication-title: Mitochondrial Bioenerg
  doi: 10.1007/978-1-61779-382-0_3
– volume: 314
  year: 2018
  ident: B3
  article-title: Guidelines for experimental models of myocardial ischemia and infarction
  publication-title: Am J Physiol Heart Circ
  doi: 10.1152/ajpheart.00335.2017
– volume: 30
  year: 2011
  ident: B13
  article-title: The role of PPAR in myocardial response to ischemia in normal and diseased heart
  publication-title: Gen Physiol Biophys
  doi: 10.4149/gpb_2011_04_329
– volume: 137
  year: 1996
  ident: B17
  article-title: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
  publication-title: Endocrinology
  doi: 10.1210/endo.137.1.8536636
– volume: 57
  year: 2020
  ident: B8
  article-title: Mitochondria in acute myocardial infarction and cardioprotection
  publication-title: Ebiomedicine
  doi: 10.1016/j.ebiom.2020.102884
– volume: 34
  year: 2010
  ident: B23
  article-title: Activation of peroxisome proliferator-activated receptor-β/δ attenuates myocardial Ischemia/Reperfusion injury in the rat
  publication-title: Shock
  doi: 10.1097/shk.0b013e3181cd86d6
– volume: 372
  year: 2007
  ident: B33
  article-title: Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor β/δ
  publication-title: J Mol Biol
  doi: 10.1016/j.jmb.2007.06.091
– volume: 1264
  year: 2015
  ident: B30
  article-title: Simultaneous high-resolution measurement of mitochondrial respiration and hydrogen peroxide production
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-4939-2257-4_22
– volume: 106
  year: 2010
  ident: B19
  article-title: Peroxisome proliferator-activated receptor δ is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.109.206185
– volume: 44
  start-page: 3
  year: 2019
  ident: B9
  article-title: Mitochondrial electron transport chain, ROS generation and uncoupling (Review)
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2019.4188
– year: 2010
  ident: B25
  article-title: Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
  publication-title: PloS Bio
  doi: 10.1371/journal.pbio.1000412
– volume: 28
  start-page: 29
  year: 2018
  ident: B46
  article-title: PGC-1: The energetic regulator in cardiac metabolism
  publication-title: Curr Issues Mol Biol
  doi: 10.21775/cimb.028.029
– volume: 55
  year: 2011
  ident: B39
  article-title: The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells
  publication-title: Diabetologia
  doi: 10.1007/s00125-011-2401-4
– volume: 120
  year: 2008
  ident: B40
  article-title: The myocardial JAK/STAT pathway: From protection to failure
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2008.08.002
– volume: 115
  year: 2007
  ident: B47
  article-title: Peroxisome proliferator–activated receptor γ coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease
  publication-title: Circulation
  doi: 10.1161/circulationaha.107.670588
– volume: 113
  year: 2018
  ident: B4
  article-title: Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection
  publication-title: Basic Res Cardiol
  doi: 10.1007/s00395-018-0696-8
– year: 2015
  ident: B21
  article-title: Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases
  publication-title: Pharm Res
  doi: 10.1016/j.phrs.2015.03.008
– volume: 386
  year: 2013
  ident: B45
  article-title: Activated peroxisomal fatty acid metabolism improves cardiac recovery in ischemia-reperfusion. naunyn-schmiedeb
  publication-title: Arch Pharmacol
  doi: 10.1007/s00210-013-0849-0
– volume: 307
  start-page: H1
  year: 2014
  ident: B48
  article-title: Physiological and structural differences in spatially distinct subpopulations of cardiac mitochondria: influence of cardiac pathologies
  publication-title: Am J Physiol Heart Circ
  doi: 10.1152/ajpheart.00747.2013
– start-page: 80 p
  volume-title: Mitochondrial pathways and respiratory control. an introduction to OXPHOS analysis
  year: 2014
  ident: B10
– volume: 92
  year: 2003
  ident: B18
  article-title: Peroxisome proliferator-activated receptor (PPAR) α and PPARβ/δ, but not PPARγ, modulate the expression of genes involved in cardiac lipid metabolism
  publication-title: Circ Res
  doi: 10.1161/01.res.0000060700.55247.7c
– volume: 106
  year: 2010
  ident: B34
  article-title: Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.110.217380
– volume: 114
  year: 2014
  ident: B49
  article-title: Cardiac mitochondria and reactive oxygen species generation
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.114.300559
– volume: 8
  year: 2019
  ident: B6
  article-title: The role of mitochondria in the mechanisms of cardiac ischemia-reperfusion injury
  publication-title: Antioxidants
  doi: 10.3390/antiox8100454
– volume: 292
  year: 2007
  ident: B42
  article-title: Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00270.2006
– volume: 34
  start-page: 37
  year: 2016
  ident: B16
  article-title: Role of pleiotropic properties of peroxisome proliferator-activated receptors in the heart: Focus on the nonmetabolic effects in cardiac protection
  publication-title: Cardiovasc Ther
  doi: 10.1111/1755-5922.12166
– volume: 95
  year: 2004
  ident: B35
  article-title: Nuclear receptor signaling and cardiac energetics
  publication-title: Circ Res
  doi: 10.1161/01.res.0000141774.29937.e3
– volume: 44
  year: 2008
  ident: B12
  article-title: The PPAR trio: Regulators of myocardial energy metabolism in health and disease
  publication-title: J Mol Cell Cardiol
  doi: 10.1016/j.yjmcc.2008.03.021
– volume: 5
  year: 2015
  ident: B27
  article-title: High-resolution respirometry for simultaneous measurement of oxygen and hydrogen peroxide fluxes in permeabilized cells, tissue homogenate and isolated mitochondria
  publication-title: Biomolecules
  doi: 10.3390/biom5031319
– volume: 283
  year: 2008
  ident: B37
  article-title: Transcriptional regulation of SDHa flavoprotein by nuclear respiratory factor-1 prevents pseudo-hypoxia in aerobic cardiac cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M709741200
– volume: 473
  year: 2016
  ident: B44
  article-title: Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria
  publication-title: Biochem J
  doi: 10.1042/bcj20160164
– volume: 22
  year: 2021
  ident: B24
  article-title: Cardioprotective effects of PPARβ/δ activation against Ischemia/Reperfusion injury in rat heart are associated with ALDH2 upregulation, amelioration of oxidative stress and preservation of mitochondrial energy production
  publication-title: Inter J Mol Sci
  doi: 10.3390/ijms22126399
– volume: 62
  year: 2013
  ident: B14
  article-title: Upregulation of genes involved in cardiac metabolism enhances myocardial resistance to ischemia/reperfusion in the rat heart
  publication-title: Physiol Res
  doi: 10.33549/physiolres.932597
SSID ssj0000401998
Score 2.373244
Snippet Myocardial ischemia/reperfusion (I/R) injury leads to significant impairment of cardiac function and remains the leading cause of morbidity and mortality...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 941822
SubjectTerms cardioprotection
electron transport system
Endocrinology
fatty acid oxidation
ischemia/reperfusion
mitochondrial respiration
ROS
Title Pharmacological activation of PPARβ/δ preserves mitochondrial respiratory function in ischemia/reperfusion via stimulation of fatty acid oxidation-linked respiration and PGC-1α/NRF-1 signaling
URI https://www.proquest.com/docview/2709016131
https://pubmed.ncbi.nlm.nih.gov/PMC9420994
https://doaj.org/article/b53a9960aa3a4fa58ac6b1296b9e28cf
Volume 13
WOSCitedRecordID wos000848383600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1664-2392
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000401998
  issn: 1664-2392
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1664-2392
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000401998
  issn: 1664-2392
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NjtMwELZghRAXxK_oAisjcUIKdeI0to_LaguXraIVSL1F_hWRaLpq0xV72XcC8Qbc-0zMONluc4ELUpVDa8dpZuyZzzP-hpC3QubK4fZSYTwAFOV5okIIiWZS55wLqSchFpsQs5mcz1W5V-oLc8I6euDuxY3NhGtkENGa6zzoidS2MGCkCqN8Jm3A1ZcJtQem4hoMsAGARBfGBBSmxsE3Dg_7Zdl7lYNTnQ0MUeTrHziZwxTJPZszfUQe9s4iPe4e8jG545sn5P5ZHw5_Sn6Xt8TT-LIpnlLo9ljpMtCyPD7f_hxvf1HMdsXUxjVdwAyGFa9xqHh0dRtop2jhYs8aPoB5_aJG9qgLvwob3FKjl7WmsCAs-oJfOELQbXsFo9aOLr_XXXmmBGPC3u3ujU1142j58SRJtz_Gs_NpklLMG9F4FP4Z-TI9_XzyKemrMiQ2z7M2sYpPWFCpB0_KAZyz6JG4NDCXSSOtcIV2TAURmeZSI5jJpTKBWW-EYkHz5-SgWTb-BaGGWbCGkmmjea69lR66FBE1W2skHxF2I6LK9pTlWDnjWwXQBaVaRalWKNWqk-qIvNt1uej4Ov7W-APKfdcQqbbjF6CAVa-A1b8UcETe3GhNBVMT4y268cvNusoEU-hR83RExECdBiMOf2nqr5HkW-V4qDk__B-P-JI8wH-NW-Hp5BU5aFcb_5rcs5dtvV4dkbtiLo_i_IHr2fXpH-6EKg0
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacological+activation+of+PPAR%CE%B2%2F%CE%B4+preserves+mitochondrial+respiratory+function+in+ischemia%2Freperfusion+via+stimulation+of+fatty+acid+oxidation-linked+respiration+and+PGC-1%CE%B1%2FNRF-1+signaling&rft.jtitle=Frontiers+in+endocrinology+%28Lausanne%29&rft.au=Papatheodorou%2C+Ioanna&rft.au=Makrecka-Kuka%2C+Marina&rft.au=Kuka%2C+Janis&rft.au=Liepinsh%2C+Edgars&rft.date=2022-08-15&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-2392&rft.volume=13&rft_id=info:doi/10.3389%2Ffendo.2022.941822&rft_id=info%3Apmid%2F36046786&rft.externalDocID=PMC9420994
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-2392&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-2392&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-2392&client=summon